Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals PSUs by Year
PSUs — Weighted-average grant-date fair value of shares granted ($/sh) ($)
Vertex Pharmaceuticals PSUs: $451 in FY2025, up 1.4% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — PSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PSUs — Weighted-average grant-date fair value of shares granted ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 451 | +1.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 445 | +39.9% | Form 10-K (filed 2025-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 318 | +28.5% | Form 10-K (filed 2024-02-15) ↗ |
| FY2022 | Dec 31, 2022 | 247 | +16.4% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 212 | -12.0% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 241 | +31.6% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 183 | +20.4% | Form 10-K (filed 2020-02-13) ↗ |
| FY2018 | Dec 31, 2018 | 152 | +75.8% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 86.71 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals PSUs ($), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/psu-granted-wafv
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.